RESPONSE RATES TO SINGLE-AGENT CARFILZOMIB IN PATIENTS DOUBLE REFRACTORY OR INTOLERANT TO BORTEZOMIB AND IMMUNOMODULATORS IN TRIAL PX-171-003-A1D. Siegel,T. Martin,M. Wang,R. Vij,A. Jakubowiak,S. Jagannath,S. Lonial,V. Kukreti,N. Bahlis,M. Alsina, A. Chanan-Khan,F. Buadi,F. Reu,G. Somlo,L. Kunkel, S. Wear,K. Rajangam,Y. Chang,R. Orlowski,K. StewartHAEMATOLOGICA(2012)引用 0|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要